ML Martín-Barbero

Background Mobility impairment is a major concern for patients with multiple sclerosis (MS). Dalfampridine improves walking speed. Nevertheless, it entails self-administration and there are few data on adherence rate, patient satisfaction and quality of life (QOL) in clinical practice. Purpose To assess adherence, QOL and degree of patient satisfaction with dalfampridine in patients treated in our hospital.

Background Prescribing errors (PE) are frequent, cause significant harm and prove costly. It is well recognised that pharmacists are a key element for safe prescription of drugs through the interception of PE during the validation process. Few studies have demonstrated the impact of pharmacist interventions. Purpose The objectives of this study were to characterise the severity and cost of the potential outcome of PE and to develop an economic analysis.